ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor concerns over Sanofi’s recent...
Search results for "Phase 3 trial"
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care
“Lately, I keep forgetting appointments.” “They keep repeating what they just said.”When memory lapses in a parent become noticeable, families almost...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment
Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...
Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third
"I’m taking my medication faithfully—so why is this happening again?"It is a deeply frustrating question that patients...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients
Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
Seoul National University Hospital to Lead 30 Billion Won Bidirectional Brain-to-Robot BCI Clinical Trials
The idea of walking by thought alone—and even regaining sensations in the soles of the feet—is edging closer to reality.
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...